
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down
|
|||||
![]() The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down ![]() A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies ![]() A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M ![]() A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company ![]() The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments ![]() Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up. . . . → Read More: Infographic – Some Good Corporate Venture Fund News ![]() Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal ![]() A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds ![]() A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds ![]() Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years. . . . → Read More: Infographic – Digital Health Venture Funds Remain Stuck |
|||||
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |